LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates

Core Insights - LifeMD, Inc. reported a quarterly loss of $0.1 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.06, representing an earnings surprise of -66.67% [1] - The company posted revenues of $60.17 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.42%, but showing an increase from $53.39 million year-over-year [2] - LifeMD shares have declined approximately 6.5% year-to-date, contrasting with the S&P 500's gain of 14.5% [3] Financial Performance - Over the last four quarters, LifeMD has surpassed consensus EPS estimates two times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.05 on revenues of $62.85 million, and for the current fiscal year, it is -$0.15 on revenues of $253.06 million [7] Market Outlook - The company's earnings outlook is mixed, with a Zacks Rank of 3 (Hold), indicating expected performance in line with the market [6] - The Medical Services industry, to which LifeMD belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8] Comparisons with Peers - HealthEquity, another company in the same industry, is expected to report quarterly earnings of $0.90 per share, reflecting a year-over-year increase of 15.4% [9] - HealthEquity's anticipated revenues are $319.96 million, which is a 6.5% increase from the previous year [10]